TELO (Telomir Pharmaceuticals) חוב לטווח קצר להון

This daily price chart for Telomir Pharmaceuticals (TELO) reflects metrics at the level of 0.03. The business leverages AI and robotics to accelerate the identification of anti-aging compounds. Telomir Pharmaceuticals (TELO) is currently in an active development stage for agents that increase telomere length to ensure longevity. The creation of innovative drugs for age-related ailments guarantees long-term demand for the company's patented solutions.

This indicator is critical for liquidity stress testing, as it allows for an assessment of the company's reliance on urgent borrowed capital relative to its net assets. By analyzing the short-term liabilities-to-capital chart, an investor can see the actual debt load of Telomir Pharmaceuticals (TELO), which remains low due to the outsourcing of production to CDMO plants and the absence of costs associated with maintaining its own facilities.